NCT01543828 - Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions

COPD

Interventions

DRUG

indacaterol

delivered via single-dose dry-powder inhaler

DRUG

placebo

delivered via single-dose dry-powder inhaler

Trial Locations (6)

Novartis Investigative Site, Raleigh

Novartis Investigative Site, Charlotte

Novartis Investigative Site, Columbus

Novartis Investigative Site, Saint Charles

Novartis Investigative Site, Fullerton

Novartis Investigative Site, Tacoma